IMPERATORI, ANDREA SELENITO
 Distribuzione geografica
Continente #
NA - Nord America 16.733
EU - Europa 10.542
AS - Asia 5.665
SA - Sud America 935
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 21
Totale 34.016
Nazione #
US - Stati Uniti d'America 16.542
IT - Italia 4.706
SG - Singapore 1.843
UA - Ucraina 1.733
CN - Cina 975
TR - Turchia 973
SE - Svezia 856
BR - Brasile 805
DE - Germania 799
VN - Vietnam 795
HK - Hong Kong 694
IE - Irlanda 528
FR - Francia 466
FI - Finlandia 454
GB - Regno Unito 381
RU - Federazione Russa 272
IN - India 106
CA - Canada 95
JP - Giappone 73
MX - Messico 72
AR - Argentina 60
ES - Italia 50
NL - Olanda 49
BD - Bangladesh 43
PL - Polonia 42
BE - Belgio 38
ZA - Sudafrica 35
EU - Europa 34
AT - Austria 33
CZ - Repubblica Ceca 30
IQ - Iraq 19
PK - Pakistan 19
EC - Ecuador 18
RO - Romania 18
UZ - Uzbekistan 18
MA - Marocco 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
AU - Australia 12
CH - Svizzera 12
CL - Cile 11
GR - Grecia 10
ID - Indonesia 10
CO - Colombia 9
EG - Egitto 9
IL - Israele 9
KZ - Kazakistan 9
PE - Perù 9
MY - Malesia 8
UY - Uruguay 8
VE - Venezuela 8
DO - Repubblica Dominicana 7
JO - Giordania 7
NZ - Nuova Zelanda 7
RS - Serbia 7
BG - Bulgaria 6
DK - Danimarca 6
PH - Filippine 5
AM - Armenia 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CR - Costa Rica 3
EE - Estonia 3
GD - Grenada 3
LU - Lussemburgo 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CG - Congo 2
DM - Dominica 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
IR - Iran 2
KG - Kirghizistan 2
MK - Macedonia 2
MM - Myanmar 2
MT - Malta 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SD - Sudan 2
SN - Senegal 2
Totale 33.997
Città #
Milan 3.244
Fairfield 1.549
Dallas 1.434
Chandler 1.406
Jacksonville 1.356
Ashburn 1.141
Singapore 1.028
Woodbridge 1.018
Houston 701
Hong Kong 690
Seattle 686
Wilmington 651
Cambridge 561
Dublin 520
Princeton 498
Izmir 470
Ann Arbor 467
Dearborn 407
Nyköping 401
Beijing 353
Dong Ket 328
Boardman 310
Los Angeles 262
New York 223
Rome 213
Como 207
Chicago 199
The Dalles 179
San Mateo 157
Munich 146
San Diego 127
Buffalo 108
Ogden 97
London 90
Santa Clara 84
São Paulo 74
Tokyo 71
Ho Chi Minh City 59
Helsinki 55
Nanjing 52
Hefei 51
Phoenix 47
Düsseldorf 46
Stockholm 45
Orem 43
Washington 42
Chennai 40
Mexico City 40
Salt Lake City 40
Denver 39
Turku 39
Brussels 38
Hanoi 37
Warsaw 37
Council Bluffs 35
Frankfurt am Main 35
Hangzhou 35
Montreal 35
Verona 35
Kunming 34
Brooklyn 33
Guangzhou 31
Atlanta 29
Toronto 29
Ankara 27
Rio de Janeiro 26
Amsterdam 25
Berlin 25
Johannesburg 25
Brno 24
Des Moines 24
Elk Grove Village 23
Kocaeli 23
Nuremberg 23
Poplar 23
Manchester 22
Nanchang 22
Belo Horizonte 21
Norwalk 21
Redmond 21
Jinan 19
Ponte Lambro 18
San Francisco 18
Boston 17
Tashkent 17
Pittsburgh 16
Querétaro 16
Tampa 15
Varese 15
Brasília 14
Campinas 14
Edinburgh 14
Falls Church 14
Mumbai 14
Vienna 14
Shanghai 13
Shenyang 13
Columbus 12
Falkenstein 12
Paris 12
Totale 23.209
Nome #
10-year follow up of 64 non-resected stage I NSCLC shows minimal overdiagnosis 1.205
Risk factors for postoperative recurrence of spontaneous pneumothorax treated by video-assisted thoracoscopic surgery 357
ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature 323
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer 302
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC 287
A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up. 277
LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer 265
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype 258
Comparison of cone-beam CT-guided and CT fluoroscopy-guided transthoracic needle biopsy of lung nodules 246
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer. 245
Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: A population-based cohort study in Varese, Italy 241
A Rare Case of Incidental Tracheal Lipoma|Caso excepcional de un hallazgo casual de lipoma traqueal 236
Management of hypertension in intrapericardial paraganglioma 234
Chest pain control with kinesiology taping after lobectomy for lung cancer: Initial results of a randomized placebo-controlled study 230
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses 228
A 90-day mortality risk model as a support in managing patients undergoing video-assisted thoracic surgery for lung cancer 226
Microwave ablation therapy for treating primary and secondary lung tumours: technical note. 225
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery. 221
Video-assisted thoracoscopic resection of lung nodules localized with a hydrogel plug† 217
Cervico-mediastinal schwannoma of the vagus nerve: resection with intraoperative nerve monitoring. 213
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 210
Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. 208
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization 208
Assessment of the aggregate risk score to predict mortality after surgical biopsy for interstitial lung disease 207
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype 204
Bronchogenic cyst associated with pericardial defect: case report and review of the literature 202
Cost of a population-based programme of chest x-ray screening for lung cancer. 201
Application of the coaxial smart drain in patients with a large air leak following anatomic lung resection: a prospective multicenter phase II analysis of efficacy and safety 201
External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids 198
An aggregate score to stratify the technical complexity of video-assisted thoracoscopic lobectomy 196
Parapancreatic Castleman disease: contrast-enhanced sonography and CT features 190
Treatment of emothorax from penetrating and contusive trauma. A single institute experience of 135 cases. 188
Il drenaggio pleuro-peritoneale nel trattamento dei versamenti neoplastici. In: La pleurodesi 186
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer 185
Bullous lung disease and neurofibromatosis type-1. 185
Peri-operative complications of video-assisted thoracoscopic surgery (VATS) 184
Diagnostic performance and complications of 396 EBUS-TBNA procedures performed under bronchoscopist-directed conscious sedation 180
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer 179
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies. 178
Surgical site infections after lung resection: A prospective study of risk factors in 1,091 consecutive patients 178
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation 177
Complicanze della biopsia polmonare video-toracoscopica in 114 casi di interstiziopatie polmonari 176
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 176
Combined adenocarcinoma–atypical carcinoid of the lung. Targeted Next-Generation Sequencing (NGS) suggests a monoclonal origin of the two components 176
Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size 173
Thyroid cancer with tracheal invasion: A pathological estimation 172
Risk factors for infections in 1.323 consecutive lung resections. A prospective study. 170
Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer. 170
Prevalence of heavy smokers in the year 2000 in the province of Varese, Italy. 169
Markers of airway inflammation in pulmonary diseases assessed by induced sputum. 169
Malignant pleural mesothelioma: time for translational research 168
Osteopontin is not a specific marker in malignant pleural mesothelioma. 167
Complications from tracheal resection for thyroid carcinoma 164
Radioimmunoguided surgery and colorectal cancer. 164
Lung cancer screening in cigarette smokers in the Province of Varese, Italy 162
High-dose intra-venous IgG for treatment of severe surgical infections 162
Videothoracoscopic (VTS) finger palpation and resection of indeterminate lung nodules ≤ 1.5 cm. Evaluation of histology by size groups 161
Resection rate of lung cancer in Teesside (UK) and Varese (Italy): a comparison after implementation of the National Cancer Plan 159
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy 158
Risultati in 108 casi consecutivi di biopsia videotoracoscopica di interstiziopatia polmonare diffusa non determinata. 157
Pulmonary resections of single metastases from colorectal cancer. 157
Characterization of apoptosis induced by marine naturalproducts in non small cell lung cancer A549 cells 157
Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours? 156
Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection 156
Self-selection effects in smokers attending lung cancer screening: a 9.5-year population-based cohort study in Varese, Italy. 155
Risk factors for infections in 1,323 consecutive lung resections. A prospective study. 153
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy 153
A CASE-REFERENT STUDY FOR EVALUATING THE EFFECTIVENESS OF LUNG CANCER SCREENING IN VARESE, ITALY 150
Simultaneous use of tracheal stent and tracheostomy tube in the management of acquired tracheal dilatation after prolonged ventilation 150
Multicentric study of endobronchial ultrasound-transbronchial needle aspiration for lung cancer staging in Italy 150
Non-small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy 149
The Society for Translational Medicine: Clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy 148
Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients 148
Risk factor for infections in 1.323 consecutive lung resections. A prospective study. 147
Infections in 346 consecutive video-assisted thoracoscopic procedures 147
Chemioprofilassi antimicrobica nei pazienti chirurgici ad alto rischio 146
NON SMALL CELL LUNG CANCER: FROM CYTOTOXIC SYSTEMIC CHEMOTHERAPY TO MOLECULARLY TARGETED THERAPY 146
Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step comparative translational study. 146
Infezioni postoperatorie e fattori di rischio: studio prospettico in 1.363 resezioni polmonari consecutive. 145
Aspetti clinicopatologici ed immunoistochimici dei mesoteliomi maligni pleurici: studio di 70 casi. 144
Alterations in lymphocyte subsets as prognosticators of post-operative infections 144
The role of the bronchial microvasculature in the airway remodelling in asthma and COPD 144
Mutations in K-ras Codon 12 Detected in Plasma DNA Are Not an Indicator of Disease in Patients with Non-Small Cell Lung Cancer. 143
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state. 141
Tumori della parete toracica: trattamento delle infezioni protesiche di parete. 140
Immediate post-operative enteral nutrition 140
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature 140
Left pneumonectomy for rapidly growing lung metastasis from phyllodes tumor 139
Financial validation of the European Society of Thoracic Surgeons risk score predicting prolonged air leak after video-assisted thoracic surgery lobectomy 139
Analysis of pneumothorax recurrence risk factors in 843 patients who underwent videothoracoscopy for primary spontaneous pneumothorax: results of a multicentric study 139
K-Ras Codon 12 mutation detected in plasma DNA is not an indicator of disease in NSCLC patients. 138
CHEST X--RAYS LUNG CANCER SCREENING IN CIGARETTE SMOKERS IN THE PROVINCE OF VARESE, ITALY 138
Nodal management and upstaging of disease: Initial results from the Italian VATS Lobectomy Registry 138
Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database 135
Impalamento trasversale toraco-mediastinico: descrizione di un caso sopravvissuto 134
Prospective study of infection risk factors in 988 lung resections. 134
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment 133
Traumatic sternal fracture: management and outcome of 46 cases. 130
Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung 130
Comparison between CBCT and fusion PET/CT-CBCT guidance for lung biopsies 130
Totale 19.006
Categoria #
all - tutte 136.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.613 0 0 0 0 0 375 106 351 566 300 327 588
2021/20222.531 370 356 175 108 111 76 138 132 128 362 228 347
2022/20233.677 337 249 250 415 262 750 5 549 496 105 159 100
2023/20245.435 831 812 846 1.014 1.007 392 42 137 162 67 25 100
2024/20254.187 37 39 696 113 104 232 172 306 493 481 451 1.063
2025/20265.523 649 818 1.130 1.313 1.174 439 0 0 0 0 0 0
Totale 34.263